Cigna Group $CI Stock Purchased by Kestra Advisory Services LLC

Kestra Advisory Services LLC lifted its stake in Cigna Group (NYSE:CI) by 15.8% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 31,601 shares of the health services provider’s stock after buying an additional 4,321 shares during the period. Kestra Advisory Services LLC’s holdings in Cigna Group were worth $8,590,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. GQG Partners LLC purchased a new stake in shares of Cigna Group during the second quarter worth about $1,628,918,000. Bank of America Corp DE bought a new stake in shares of Cigna Group in the second quarter worth about $827,692,000. Legal & General Group Plc purchased a new position in Cigna Group during the 2nd quarter valued at about $542,779,000. The Manufacturers Life Insurance Company purchased a new position in Cigna Group during the 2nd quarter valued at about $241,312,000. Finally, BlackRock Inc. increased its holdings in Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after purchasing an additional 840,098 shares during the period. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

CI stock opened at $302.30 on Wednesday. Cigna Group has a 1 year low of $257.85 and a 1 year high of $318.05. The company has a market cap of $79.88 billion, a P/E ratio of 13.34, a PEG ratio of 1.10 and a beta of 0.25. The firm has a 50-day moving average of $286.66 and a 200 day moving average of $282.38. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, topping the consensus estimate of $7.52 by $0.46. The business had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. Cigna Group’s quarterly revenue was up 5.6% compared to the same quarter last year. During the same period last year, the business posted $7.83 earnings per share. On average, sell-side analysts forecast that Cigna Group will post 30.70 EPS for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Thursday, December 3rd. Cigna Group’s dividend payout ratio (DPR) is presently 27.54%.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Recent coverage says strong Q3 growth has lifted Cigna’s 2026 earnings outlook, offering a favorable signal about business performance and the company’s earnings trajectory. The Cigna Group stock: Higher outlook follows strong Q3 performance
• Positive Sentiment: Barclays raised its price target to $320 from $310, implying potential upside from the referenced $302.30 price. However, it maintained an “equal weight” rating, indicating a balanced rather than strongly bullish view. Barclays price target update
• Neutral Sentiment: The Cigna Group Foundation awarded $3.45 million to 23 nonprofits supporting housing stability and mental health for veterans and their families. This highlights community investment but is not likely to have a significant direct effect on earnings. Cigna Foundation veteran grants
• Neutral Sentiment: Cigna’s CFO is scheduled to speak at the UBS Global Healthcare Conference, which could provide investors with updates but is not itself a financial announcement. UBS Global Healthcare Conference appearance
• Neutral Sentiment: Cigna Healthcare Hong Kong is expanding access to Headspace’s self-guided mental-wellbeing resources. The partnership may support its service offering, though the report provides no financial impact. Headspace resources in Hong Kong
• Negative Sentiment: Guggenheim cut its price target for Cigna, a cautious counterpoint to Barclays’ increase. The report provided here does not specify the revised target or rating. Guggenheim price target update

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Guggenheim cut their price objective on Cigna Group from $361.00 to $347.00 and set a “buy” rating on the stock in a research report on Friday, November 6th. Evercore initiated coverage on Cigna Group in a research note on Wednesday, September 9th. They set an “in-line” rating and a $290.00 target price on the stock. Jefferies Financial Group downgraded Cigna Group from a “buy” rating to a “hold” rating and decreased their target price for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $337.00 price target on shares of Cigna Group in a research note on Thursday, October 1st. Fourteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and an average price target of $336.20.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.